TCL6 and laryngotracheoesophageal cleft: Of note, lnc-TCL6 could detect early-stage LC (CP-A) with a sensitivity of 83.67% compared with healthy controls and with a specificity of >95% compared with HBV-infection patients (including HBV carrier and CHB) through the analysis of ROC curves.